TheProductLawyers.com reports on a South Florida resident whose husband died from internal bleeding while taking Xarelto, a new-generation blood thinner released on the market in 2011 after its approval by the U.S. Food and Drug Administration (FDA). The deceased's wife filed a lawsuit on his behalf against the manufacturers of the drug, Janssen Pharmaceuticals, a subsidiary of the Johnson and Johnson Corporation, and Bayer Healthcare, stating they did not adequately warn consumers about the dangerous risks related to taking Xarelto, specifically the potential for significant and uncontrollable bleeding.
The plaintiff, in this case, alleges that Janssen and Bayer are responsible for her husband's death because of bleeding that doctors were unable to stop. He died from a subdural hemorrhage. The deceased was taking Xarelto to decrease his risk of having a stroke that he was susceptible to because of his heart condition, atrial fibrillation.
When Xarelto was released it was touted as being different than the traditional blood thinners that came before it because patients taking it did not have to be constantly monitored nor did they require special diets. The drug was very popular upon its release yet quickly became associated with serious side effects as plaintiffs began filing lawsuits claiming the drug caused episodes of uncontrollable bleeding.
Xarelto now is the focus of 2,800 lawsuits filed in federal courts all across the United States. It is also the subject of 550 more in a mass tort program in Philadelphia, PA.
Recent actions taken by the FDA also seem to verify the alleged risks associated with taking Xarelto with its issuance of two black box warnings for the drug. A black box warning is considered to be the harshest that can be given to a product before being ordered to remove it from the consumer market.
The attorneys of Banville Law, the firm behind TheProductLawyers.com, are offering complimentary consultations to anyone who suffered injury or hospitalization after a bleed while on Xarelto. For more information about this release or the Xarelto litigation call 888-478-9711.
TheProductLawyers.com is a resource website sponsored by Banville Law to provide information on pending lawsuits against defective products, drugs and medical devices.
165 West End Ave #1h,
New York, NY 10023
November 30, 2016 – Research Indicates New Form Of Treating Ovarian Cancer As Talcum Powder Lawsuit Numbers Climb
November 30, 2016 – Parties in Talcum Powder Lawsuit In Missouri Exchange Briefings
November 30, 2016 – J&J Requests Disclosure Of Third Party Litigation Financing In Talcum Powder Lawsuit
November 30, 2016 – Delaware Sees 10 New Talcum Powder Lawsuit Filings
November 29, 2016 – Philadelphia Talcum Powder Lawsuit Filed Against Johnson & Johnson To Proceed
November 29, 2016 – Pennsboro Woman Files Talcum Powder Lawsuit On Behalf Of Her Deceased Mother
November 29, 2016 – Bioimaging Helps Early Detection Of Ovarian Cancer As Talcum Powder Lawsuit Filings Continue
November 28, 2016 – FDA Follow-Up: How Officials Have Responded To The Influx Of Talcum Powder Lawsuit Filings
November 28, 2016 – Talc Uses: A Look At The Product At The Center Of Talcum Powder Lawsuit Filings
November 28, 2016 – More Women Encouraged To File A Talcum Powder Lawsuit After Verdicts